Intravenous treatment of chronic daily headaches in the outpatient headache clinic

Current Pain and Headache Reports

Volumn 10, Issue 1, 2006, Pages 47-53

  Krusz, John Claude ^a  

^a Anodyne Headache and PainCare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; ANTIEMETIC AGENT; CHLORPROMAZINE; DEXAMETHASONE; DEXTROMETHORPHAN; DIHYDROERGOTAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; DULOXETINE; ERGOTAMINE; ETIRACETAM; KETAMINE; LIDOCAINE; LORAZEPAM; MAGNESIUM SULFATE; MEMANTINE; METOCLOPRAMIDE; PHENCYCLIDINE; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; STEROID; SUMATRIPTAN; TOPIRAMATE; TRAMADOL; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

AKATHISIA; ANALGESIA; ANXIETY DISORDER; CHRONIC DAILY HEADACHE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; EMERGENCY WARD; EXPERIENCE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; REVIEW; SOMNOLENCE; TRANSFORMED MIGRAINE;

AMBULATORY CARE FACILITIES; ANALGESICS; ANESTHETICS; ANTIEMETICS; GABA AGENTS; HEADACHE DISORDERS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; VASOCONSTRICTOR AGENTS;

EID: 33645058911     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-006-0009-z     Document Type: Review

References (51)

1. Krusz JC, Scott-Krusz V, Cagle J, Belanger J: Outpatient clinic treatment of headache and migraine flare-ups. Poster abstract presented at: EFNS. Athens, Greece: September 2005.
2. Krusz JC, Belanger J: Cost effectiveness of clinic treatment of headaches and pain. Oral platform presented at 8th World Congress. Tenerife, Canary Islands: The Pain Clinic, 1998.
3. Richter PA, Burk MP: The potentiation of narcotic analgesics with phenothiazines. J Foot Surg 1992, 31:378-380.
4. Vinson DR: Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 2002, 39:215-222.
5. Friedman BW, Corbo J, Lipton RB, et al.: A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005, 64:463-468.
6. Taylor BK, Joshi C, Uppal H: Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 2003, 987:135-143.
7. Flores JA, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E: Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 2004, 110:205-214.
8. King MA, Bradshaw S, Chang AH, et al.: Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active antiopioid system. J Neurosci 2001, 21:7788-7792.
9. Semenchuk MR, Davis B: Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. Clin J Pain 2000, 16:6-11.
10. Wang SJ, Silberstein SD, Young WB: Droperidol treatment of status migrainosus and refractory migraine. Headache 1997, 37:377-382.
11. Krusz JC, Scott VB, Belanger J IV: Droperidol as a treatment for acute migraine headache. Poster presented at the International Headache Society World Congress. Barcelona: June 1999. Cephalalgia 1999, 19:356.
12. Silberstein SD, Young WB, Mendizabal JE, et al.: Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 2003, 60:315-321.
13. Jones J, Pack S, Chun E: Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996, 14:262-264.
14. Ginder S, Oatman B, Pollack M: A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med 2000, 18:311-315.
15. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996, 36:154-160.
16. Krusz JC, Belanger J: Intravenous magnesium sulfate in the treatment of headaches. Poster presented at the American Academy of Pain Management Annual Meeting. Atlanta: September 1998.
17. Mauskop A, Altura BM: Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998, 5:24-27.
18. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995, 35:597-600.
19. Unger J, Cady RK, Farmer-Cady K: Understanding migraine: treatment options. Emerg Med 2003, 9:50-55.
20. Raskin NH: Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986, 36:995-997.
21. Scherl ER, Wilson JF: Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995, 35:256-259.
22. Klapper J: The pharmacologic treatment of acute migraine headaches. J Pain Symptom Manage 1993, 8:140-147.
23. Klapper JA, Stanton JS: Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache 1991, 31:523-524.
24. Rozen TD: Migraine headache: immunosuppressant therapy. Curr Treat Options Neurol 2002, 4:395-401.
25. Saadah HA: Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache 1994, 34:366-370.
26. Gallagher RM: Emergency treatment of intractable migraine. Headache 1986, 28:74-75.
27. Hering R, Kuritsky A: Sodium valproate has a prophylaxis effect in migraine: a double-blind study vs placebo. Cephalalgia 1992, 12:81-48.
28. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura. Neurology 1994, 44:647-651.
29. Klapper JA: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997, 17:103-108.
30. Krusz JC, Scott VB, Belanger J: Intravenous valproate sodium in the treatment of refractory migraine headaches. Poster presented at the Headache Update Annual Meeting. Orlando: July 1999.
31. Mathew NT, Kailasam J, Meadors L, et al.: Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000, 40:720-723.
32. Edwards KR, Norton J, Behnke M: Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001, 41:976-980.
33. Krusz JC: Intravenous valproate sodium in the treatment of migraine headaches in the headache clinic. Headache Quarterly 2003, 12:39-41.
34. Schwartz TH, Karpitskiy VV, Sohn RS: Intravenous valproate sodium in the treatment of daily headache. Headache 2002, 42:519-522.
35. Tanen DA, Miller S, French T, Riffenburgh RH: Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 2003, 41:847-853.
36. Stillman MJ, Zajac D, Rybicki LA: Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache 2004, 44:65-69.
37. Krusz JC, Scott V, Belanger J: Intravenous propofol: unique effectiveness in treating intractable migraine headaches. Headache 2000, 40:41-46.
38. Krusz JC: Prophylaxis for chronic daily headache and chronic migraine with neuronal stabilizing agents. Curr Pain Headache Rep 2002, 6:480-485.
39. Bell R, Montoya D, Shuaib A, Lee MA: A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990, 19:1079-1082.
40. Reutens DC, Fatovich DM, Stewart-Wynne EC, Prentice DA: Is intravenous lidocaine clinically effective in acute migraine? Cephalaigia 1991, 11:245-247.
41. Hand PJ, Stark RJ: Intravenous lignocaine infusions for severe chronic daily headache. Med J Aust 2000, 172:157-159.
42. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003, 23:963-971.
43. Krusz JC, Longmire DR: Tramadol in the treatment of headaches [Abstract]. Poster presented at the American Academy of Pain Management Annual Meeting. Washington, DC: September 1996.
44. Krusz JC, Daniel D, Cagle J: IV tramadol for treating-refractory migraines [Abstract]. Poster presented at the 7th Congress European Federation of Neurological Societies. Helsinki, Finland: August 2003. Eur J Neurol 2003, 10 (suppl 1):74-75.
45. Krusz JC: Levetiracetam (Keppra™) as prophylaxis for resistant headaches [Abstract]. Poster presented at the Headache Update 2000. Lake Buena Vista, FL. Headache Quarterly 2000, 12:54.
46. Krusz JC, Cagle J, Daniel D: Intravenous levetiracetam for acute intractable migraines. Poster presented at the 14th Migraine Trust International Symposium. London: September 2002. Cephalalgia 2002, 22:604.
47. Krusz JC, Daniel D, Cagle J: IV Levetiracetam efficacious for cluster headache. Poster presented at the XI Congress of the International Headache Society. Rome: September 2003. Cephalalgia 2003, 23:736.
48. Nicolodi M, Sicuteri F: Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res 1995, 15:181-189.
49. Nicolodi M, Sicuteri F: Negative modulators of excitatory amino acids in episodic and chronic migraine: preventing and reverting chronic migraine. Special lecture at the 7th INWIN Congress. Int J Clin Pharmacol Res 1998, 18:93-100.
50. Kaube H, Herzog J, Kaufer T, et al.: Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000, 55:139-141.
51. Peres MF, Zukerman E, Soares C, et al.: CSF glutamate levels in chronic migraine [Abstract]. Cephalalgia 2004, 24:151-152.